簡介

本頁面提供了有關 Pascale Witz 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Pascale Witz已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:RVTY / Revvity, Inc. Director 15,985
US:RGLS / Regulus Therapeutics Inc. Director 0
US:HZNP / Horizon Therapeutics Plc Director 0
US:TSRO / TESARO, Inc. Director 0
如何解讀這些圖表

以下圖表顯示了在Pascale Witz進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Pascale Witz 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-11 2026-05-07 4 RVTY REVVITY, INC.
Common Stock
A - Award 1,265 15,985 8.59
2026-05-11 2026-05-07 4 RVTY REVVITY, INC.
Common Stock
A - Award 1,015 14,720 7.41
2025-06-27 2025-06-25 4 RGLS Regulus Therapeutics Inc.
Common Stock
D - Sale to Issuer -67,233 0 -100.00
2025-05-01 2025-04-30 4 RVTY REVVITY, INC.
Common Stock
A - Award 1,338 13,705 10.82
2025-05-01 2025-04-30 4 RVTY REVVITY, INC.
Common Stock
A - Award 1,074 12,367 9.51
2025-04-30 2025-04-30 4 RGLS Regulus Therapeutics Inc.
Common Stock
A - Award 62,500 67,233 1,320.52
2024-05-02 2024-05-01 4 RVTY REVVITY, INC.
Common Stock
A - Award 1,218 11,293 12.09
2024-05-02 2024-05-01 4 RVTY REVVITY, INC.
Common Stock
A - Award 977 10,075 10.74
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -20,279 0 -100.00 116.50 -2,362,504
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -25,672 0 -100.00 116.50 -2,990,788
2023-05-17 2023-05-15 4 RVTY REVVITY, INC.
Common Stock
A - Award 955 9,098 11.73
2023-05-17 2023-05-15 4 RVTY REVVITY, INC.
Common Stock
A - Award 783 8,143 10.64
2023-05-02 2023-04-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1,879 16,323 -10.32 111.16 -208,870 1,814,465
2023-05-02 2023-04-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 3,913 18,202 27.38
2022-05-09 2022-05-06 4 PKI PERKINELMER INC
Common Stock
A - Award 744 7,360 11.25
2022-05-09 2022-05-06 4 PKI PERKINELMER INC
Common Stock
A - Award 610 6,616 10.16
2022-05-02 2022-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -4,223 0 -100.00
2022-05-02 2022-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1,658 43,917 -3.64 98.56 -163,412 4,328,460
2022-05-02 2022-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 4,223 45,575 10.21
2022-05-02 2022-04-28 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 3,913 3,913
2021-06-15 2021-06-14 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2021-05-10 2021-05-07 4 PKI PERKINELMER INC
Common Stock
A - Award 709 6,006 13.38
2021-05-10 2021-05-07 4 PKI PERKINELMER INC
Common Stock
A - Award 604 5,297 12.87
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -11,098 0 -100.00
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -4,357 41,352 -9.53 94.62 -412,259 3,912,726
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 11,098 45,709 32.06
2021-04-30 2021-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 4,223 4,223
2020-08-04 2020-08-02 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -8,204 0 -100.00
2020-08-04 2020-08-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3,221 34,611 -8.51 61.19 -197,093 2,117,847
2020-08-04 2020-08-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 8,204 37,832 27.69
2020-06-19 2020-06-17 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 23,250 23,250
2020-05-12 2020-05-08 4 PKI PERKINELMER INC
Common Stock
A - Award 1,081 4,693 29.93
2020-05-12 2020-05-08 4 PKI PERKINELMER INC
Common Stock
A - Award 244 3,612 7.24 92.20 22,497 333,026
2020-05-12 2020-05-08 4 PKI PERKINELMER INC
Common Stock
A - Award 922 3,368 37.69
2020-05-04 2020-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -15,390 0 -100.00
2020-05-04 2020-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -6,041 29,628 -16.94 35.62 -215,180 1,055,349
2020-05-04 2020-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 15,390 35,669 75.89
2020-05-04 2020-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 11,098 11,098
2019-12-26 2019-12-24 4 RGLS Regulus Therapeutics Inc.
Common Stock Purchase Warrant (Right to Buy)
A - Award 67,700 67,700 0.12 8,462 8,462
2019-12-26 2019-12-24 4 RGLS Regulus Therapeutics Inc.
Class A-2 Convertible Preferred Stock
A - Award 6,770 6,770 6.66 45,088 45,088
2019-11-22 2019-11-21 4 PKI PERKINELMER INC
Common Stock
S - Sale -1,043 2,446 -29.89 90.67 -94,569 221,779
2019-10-15 2019-10-10 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 46,500 46,500
2019-08-05 2019-08-02 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -8,203 8,204 -50.00
2019-08-05 2019-08-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3,220 20,279 -13.70 24.64 -79,341 499,675
2019-08-05 2019-08-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 8,203 23,499 53.63
2019-05-21 2019-05-07 4/A RGLS Regulus Therapeutics Inc.
Common Stock Purchase Warrant (Right to Buy)
A - Award 29,630 29,630 0.12 3,704 3,704
2019-05-21 2019-05-07 4/A RGLS Regulus Therapeutics Inc.
Common Stock
A - Award 29,630 37,849 360.51 1.08 32,000 40,877
2019-05-08 2019-05-07 4 RGLS Regulus Therapeutics Inc.
Common Stock Purchase Warrant (Right to Buy)
P - Purchase 29,630 29,630 0.12 3,704 3,704
2019-05-08 2019-05-07 4 RGLS Regulus Therapeutics Inc.
Common Stock
P - Purchase 29,630 37,849 360.51 1.08 32,000 40,877
2019-05-06 2019-05-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -15,320 0 -100.00
2019-05-06 2019-05-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -6,014 15,296 -28.22 26.54 -159,612 405,956
2019-05-06 2019-05-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 15,320 21,310 255.76
2019-05-06 2019-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 15,390 15,390
2019-05-01 2019-04-30 4 PKI PERKINELMER INC
Common Stock
A - Award 1,043 3,489 42.64
2019-05-01 2019-04-30 4 PKI PERKINELMER INC
Common Stock
A - Award 785 2,446 47.26
2019-01-22 2019-01-22 4 TSRO TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
D - Sale to Issuer -14,221 0 -100.00
2019-01-22 2019-01-22 4 TSRO TESARO, Inc.
Director Restricted Stock Units
D - Sale to Issuer -8,104 0 -100.00
2019-01-22 2019-01-22 4 TSRO TESARO, Inc.
Common Stock
U - Other -1,279 0 -100.00 75.00 -95,925
2018-11-13 2018-11-12 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -4,583 0 -100.00
2018-11-13 2018-11-12 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -6,250 0 -100.00
2018-11-13 2018-11-12 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -5,000 0 -100.00
2018-11-13 2018-11-12 4 RGLS Regulus Therapeutics Inc.
Common Stock
A - Award 15,833 19,625 417.54
2018-11-07 2018-11-06 4 PKI PERKINELMER INC
Common Stock
S - Sale -2,206 1,661 -57.05 83.62 -184,455 138,885
2018-08-02 2018-08-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -8,203 16,407 -33.33
2018-08-02 2018-08-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -2,213 5,990 -26.98 18.18 -40,232 108,898
2018-08-02 2018-08-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 8,203 8,203
2018-07-03 2018-06-01 4/A TSRO TESARO, Inc.
Director Restricted Stock Units
A - Award 8,104 8,104
2018-07-03 2018-06-01 4/A TSRO TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
A - Award 14,221 14,221
2018-07-03 2018-06-01 4/A TSRO TESARO, Inc.
Common Stock
A - Award 1,279 1,279
2018-06-05 2018-06-01 4 TSRO TESARO, Inc.
Director Restricted Stock Units
A - Award 4,052 4,052
2018-06-05 2018-06-01 4 TSRO TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
A - Award 7,209 7,209
2018-06-05 2018-06-01 4 TSRO TESARO, Inc.
Common Stock
A - Award 1,279 1,279
2018-06-05 2018-06-01 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 55,000 55,000
2018-05-21 2018-05-17 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 75,000 75,000
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 15,320 15,320
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 32,161 32,161
2018-05-04 2018-05-03 4 PKI PERKINELMER INC
Common Stock
A - Award 1,386 3,867 55.86
2018-05-04 2018-05-03 4 PKI PERKINELMER INC
Common Stock
A - Award 1,043 2,481 72.53
2017-12-06 2017-12-04 4 RGLS Regulus Therapeutics Inc.
Common Stock
A - Award 60,674 60,674 0.89 54,000 54,000
2017-11-16 2017-11-15 4 PKI PERKINELMER INC
Common Stock
A - Award 820 1,438 132.69
2017-11-16 2017-11-15 4 PKI PERKINELMER INC
Common Stock
A - Award 618 618
2017-08-03 2017-08-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 24,610 24,610
2017-08-03 2017-08-02 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 52,232 52,232
2017-06-02 2017-06-01 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 60,000 60,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)